0
HPV-DeepSeek assay shows 98.7 percent sensitivity, 99.1 percent specificity.
Targets 43 HPV genotypes, crucial for early cancer detection.
Study involved 224 patients with HPV-associated squamous cell carcinoma.
High median genome coverage near 100 percent in true-positive cases.
Reports PIK3CA mutations and viral integration patterns.
Observations align with established cancer-site-specific tendencies.
Potential applications in treatment monitoring and assessing residual disease.
